Birdwatch Note
2024-08-04 02:06:32 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ターボ癌という医学用語は存在せず、SNS上で拡散されている造語で科学的根拠もありません https://www.sankei.com/article/20221209-7LLB3VRMZZBUFADO7VUPKN2RPY/ mRNAワクチンが免疫力を低下させ癌を誘発するという科学的根拠はありません むしろ、mRNAワクチンによる癌治療が始まっています https://www.cas.org/ja/resources/cas-insights/biotechnology/fighting-viruses-tackling-tumors-harnessing-mrna-vaccines https://www.igakuken.or.jp/r-info/covid-19-info168.html
Written by 456D8E5FC165A448157B67AFD44D243BBDCE4A8244E667468753522761C180F1
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819726048289775969
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819917806668050489
- noteId - 1819917806668050489
- participantId -
- noteAuthorParticipantId - 456D8E5FC165A448157B67AFD44D243BBDCE4A8244E667468753522761C180F1 Participant Details
- createdAtMillis - 1722737192204
- tweetId - 1819726048289775969
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ターボ癌という医学用語は存在せず、SNS上で拡散されている造語で科学的根拠もありません https://www.sankei.com/article/20221209-7LLB3VRMZZBUFADO7VUPKN2RPY/ mRNAワクチンが免疫力を低下させ癌を誘発するという科学的根拠はありません むしろ、mRNAワクチンによる癌治療が始まっています https://www.cas.org/ja/resources/cas-insights/biotechnology/fighting-viruses-tackling-tumors-harnessing-mrna-vaccines https://www.igakuken.or.jp/r-info/covid-19-info168.html
Note Ratings
rated at | rated by | |
2024-08-20 08:03:35 -0500 | Rating Details | |
2024-08-20 04:30:52 -0500 | Rating Details | |
2024-08-19 06:58:02 -0500 | Rating Details | |
2024-08-19 05:47:38 -0500 | Rating Details | |
2024-08-16 03:28:39 -0500 | Rating Details | |
2024-08-16 03:15:18 -0500 | Rating Details | |
2024-08-15 23:40:55 -0500 | Rating Details | |
2024-08-15 21:08:23 -0500 | Rating Details | |
2024-08-07 14:42:49 -0500 | Rating Details | |
2024-08-07 02:17:35 -0500 | Rating Details | |
2024-08-07 01:01:00 -0500 | Rating Details | |
2024-08-07 00:32:42 -0500 | Rating Details | |
2024-08-06 22:15:08 -0500 | Rating Details | |
2024-08-06 21:14:05 -0500 | Rating Details | |
2024-08-06 21:01:01 -0500 | Rating Details | |
2024-08-06 11:59:59 -0500 | Rating Details | |
2024-08-04 23:34:53 -0500 | Rating Details | |
2024-08-04 20:26:05 -0500 | Rating Details | |
2024-08-04 17:02:55 -0500 | Rating Details | |
2024-08-04 16:27:15 -0500 | Rating Details | |
2024-08-04 08:48:33 -0500 | Rating Details | |
2024-08-04 06:46:00 -0500 | Rating Details | |
2024-08-04 01:43:08 -0500 | Rating Details | |
2024-08-04 01:37:42 -0500 | Rating Details | |
2024-08-04 01:20:30 -0500 | Rating Details | |
2024-08-04 01:18:55 -0500 | Rating Details | |
2024-08-04 01:18:05 -0500 | Rating Details | |
2024-08-04 01:15:17 -0500 | Rating Details | |
2024-08-04 01:08:18 -0500 | Rating Details | |
2024-08-04 01:01:39 -0500 | Rating Details | |
2024-08-04 00:41:04 -0500 | Rating Details | |
2024-08-04 00:38:34 -0500 | Rating Details | |
2024-08-04 00:34:56 -0500 | Rating Details | |
2024-08-04 00:32:33 -0500 | Rating Details | |
2024-08-04 00:30:21 -0500 | Rating Details | |
2024-08-04 00:30:09 -0500 | Rating Details | |
2024-08-04 00:14:43 -0500 | Rating Details | |
2024-08-04 00:14:31 -0500 | Rating Details | |
2024-08-04 00:02:34 -0500 | Rating Details | |
2024-08-04 00:02:23 -0500 | Rating Details | |
2024-08-03 23:54:18 -0500 | Rating Details | |
2024-08-03 23:48:27 -0500 | Rating Details | |
2024-08-03 23:45:45 -0500 | Rating Details | |
2024-08-03 23:35:34 -0500 | Rating Details | |
2024-08-03 23:33:57 -0500 | Rating Details | |
2024-08-03 23:28:54 -0500 | Rating Details | |
2024-08-03 23:27:34 -0500 | Rating Details | |
2024-08-03 23:19:12 -0500 | Rating Details | |
2024-08-03 23:18:02 -0500 | Rating Details | |
2024-08-03 23:03:17 -0500 | Rating Details | |
2024-08-03 22:44:54 -0500 | Rating Details | |
2024-08-03 22:44:42 -0500 | Rating Details | |
2024-08-03 22:40:21 -0500 | Rating Details | |
2024-08-03 22:26:19 -0500 | Rating Details | |
2024-08-03 22:17:46 -0500 | Rating Details | |
2024-08-03 22:07:10 -0500 | Rating Details | |
2024-08-03 21:44:41 -0500 | Rating Details | |
2024-08-03 21:42:34 -0500 | Rating Details | |
2024-08-03 21:33:00 -0500 | Rating Details | |
2024-08-03 21:27:14 -0500 | Rating Details | |
2024-08-03 21:14:08 -0500 | Rating Details | |
2024-08-03 21:07:14 -0500 | Rating Details | |
2024-08-19 12:54:52 -0500 | Rating Details | |
2024-08-17 09:36:06 -0500 | Rating Details | |
2024-08-06 21:35:56 -0500 | Rating Details | |
2024-08-04 09:20:12 -0500 | Rating Details | |
2024-08-04 09:19:30 -0500 | Rating Details | |
2024-08-04 00:26:53 -0500 | Rating Details | |
2024-08-04 00:11:21 -0500 | Rating Details | |
2024-08-03 23:36:01 -0500 | Rating Details | |
2024-08-03 23:19:36 -0500 | Rating Details | |
2024-08-03 23:15:47 -0500 | Rating Details | |
2024-08-03 23:15:32 -0500 | Rating Details | |
2024-08-03 22:40:34 -0500 | Rating Details | |
2024-08-03 22:09:22 -0500 | Rating Details | |
2024-08-03 21:20:40 -0500 | Rating Details |